immunome.com (IMNM) Company Sales Volume

Immunome - graphic logo of issuer IMNM

Immunome, Inc. (IMNM) maintains a positive image as a bold innovator in oncology, which is supported by the company's consolidated sales dynamics, where 0.00 determines the current status of the parameter. The business relies on R&D platforms for antibody discovery, attracting scientists through a flexible culture and stock options. The integration of survivor patient data enables the identification of unique targets for combating viruses and cancer, creating a high-tech development ecosystem.

IMNM Immunome, Inc.: Revenue and Sales Volume in the range 07/04/2022 - 11/16/2026

Analytical breakdowns for Immunome, Inc.

- price and consensus price forecast:
General company analysis:IMNM, immunome.com
Signature product of Immunome Corp

Immunome, Inc. (IMNM) develops exclusive antibody-based drugs, enabling the company to leverage monopoly pricing power. By analyzing the company's product sales revenue, investors track the daily volume of commercial inflows. This metric captures the actual cash flow from clients, reflecting the current stage of development monetization. The trend of this indicator serves as an objective gauge of business scaling without time lags. Steady revenue growth confirms the market value of the platform and its capitalization potential.

Analysis of competing companies

Revenue and Sales Volume argenx.com|Company Revenue BioNTech Group (BNTX)|Abivax S.A. - Company Sales Volume|Revenue and Sales Volume ADMA (admabiologics.com)|Protagonist Corp (PTGX) - Company Total Revenue|immunovant.com - Revenue and Sales Volume|KNSA - Revenue and Sales Volume|Grifols (GRFS) - Company Revenue|Company Sales Volume ADPT|Company Revenue Celldex|AUPH: Company Sales Revenue|Revenue and Sales Volume BCRX|Revenue and Sales Volume Vera Therapeutics (VERA)|Dianthus Therapeutics - Company Sales|Pharvaris - Company Revenue|ABCL - Company Revenue|TRML - Revenue and Sales Volume|PGEN: Revenue and Sales Volume|Company Sales Volume PHAR|Company Sales NKTR|UPB: Company Sales Revenue|Company Revenue zenasbio.com (ZBIO)|GOSS (Gossamer Corp) - Company Sales Revenue|Company Revenue KalVista Pharmaceuticals Inc KALV|Company Gross Revenue septerna.com (SEPN)|PVLA - Company Revenue|Company Gross Revenue Savara Inc SVRA|RIGL: Revenue and Sales Volume|ANAB - Company Gross Revenue|Company Revenue Astria Pharma|Company Sales Volume ENGN (enGene Holdings Inc.)|Company Sales RAPT (RAPT Therapeutics, Inc.)|Revenue and Sales Volume Aerovate Therapeutics, Inc. (JBIO)|Revenue and Sales Volume ACRS (aclaristx.com)|Kyverna Therapeutics (KYTX) - Company Total Revenue|tizianalifesciences.com - Revenue and Sales Volume|CABA (Cabaletta Bio, Inc.) - Company Sales Volume|VTYX: Revenue and Sales Volume|THTX - Company Gross Revenue|Company Revenue Avalo Therapeutics Inc|Eledon (ELDN) - Company Gross Revenue|Company Revenue agenusbio.com (AGEN)|CLYM (Climb Bio Inc) - Company Sales Revenue|Revenue and Sales Volume ZURA (zurabio.com)|Company Sales Revenue ATYR|ADAG - Company Revenue|ikenaoncology.com (IMA) - Company Sales|Shattuck Labs (STTK) - Company Revenue|EQ - Company Gross Revenue|CNTB (connectbiopharm.com) - Revenue and Sales Volume|IMUX: Company Sales Revenue|Company Revenue Atara Biotherapeutics, Inc. (ATRA)|Company Gross Revenue InflaRx NV|Revenue and Sales Volume XFOR (X4 Pharmaceuticals)|Revenue and Sales Volume Adicet Bio ACET|CELU: Company Sales|Company Sales Revenue INMB (INmune Bio)|Barinthus Bio (BRNS) - Company Revenue|Kezar Life Sciences (KZR) - Revenue and Sales Volume|Company Revenue sabbiotherapeutics.com|Revenue and Sales Volume Akari Therapeutics Plc|Company Revenue Enlivex Therapeutics Ltd (ENLV)|Q32 Bio Corp (QTTB) - Company Total Sales Volume|Company Revenue GeoVax Corp GOVX|Company Gross Revenue Edesa Biotech Corp (EDSA)|IBIO: Company Sales|Company Sales Revenue CARM (carismatx.com)|XTLB: Revenue and Sales Volume|BOLT - Company Gross Revenue|Company Sales HCWB|Company Sales Aptevo Therapeutics Inc. (APVO)|Revenue and Sales Volume AIM|ADTX: Company Annual Revenue|GRI Bio - Company Sales|Company Gross Revenue XORTX Therapeutics Inc (XRTX)|HIND: Company Sales|Revelation Biosciences (REVB) - Company Sales|Indaptus Therapeutics, Inc. (INDP) - Company Revenue|SCNI - Company Gross Revenue|CALI (CalciMedica) - Revenue and Sales Volume|Revenue and Sales Volume affimed.com|Company Revenue Allakos Therapeutics (ALLK)|HOOK - Company Total Revenue|Company Revenue IGM Biosciences, Inc. IGMS|Company Gross Revenue iTeos Therapeutics, Inc. (ITOS)|Ocean Biomedical Corp - Revenue and Sales Volume|TC BioPharm (TCBP) - Company Sales|THRD: Revenue and Sales Volume